Hospital-based Cross-sectional Study on Demographic Aspects of Hormonal Contraception Use and its Association with Depression Among Somali Women in Mogadishu
Though hormonal contraception is known to precipitate depression in some women, it is a successful public health initiative and has numerous personal and community advantages. It contributes to reducing unsafe abortions and maternal and child mortality. The purpose of this study was to assess the prevalence of depression among women who use the hormonal contraceptive (HC) method in Mogadishu, which at times led to circumstances for discontinuation of the contraceptives. A hospital-based cross-sectional study was conducted among women who use HCs and attend a tertiary Benadir mother-and-child hospital and a Somali-Sudanese hospital in Mogadishu, Somalia, from August 2022 to December 2022. The data were collected using Patient Health Questionnaire-9 (PHQ-9). Data were analysed in both descriptive and inferential statistics such as percentage, t-test, analysis of variance, and binary as well as multiple logistic regression. On the HC usage characteristics, 43.6% of the participants have been on Jadelle Implants (a levonorgestrel-releasing implant), with a significance, while only 18.1% use pills (progestin and oestrogen), and the rest used Norplant capsules. In evaluating the physiological side effect incurred by respective HC, 39.6% of respondents were taking anti-depression therapy with a comparative significance, 78.9 were in overall good health, while 21.1% of participants were in poor health. Based on PHQ-9 majority of the respondents (26.9%) had moderate depression, and thirteen (13.1%) had minimal depression, fifty (22.0%) had mild depression. Yet, 43 (18.9%) experienced moderate depression, while another 43 (18.9%) had severe depression. Female housewives were 1.91 times more at risk of any form of depressive disorder than those who are employed. Respondents who had more than $600 were 0.45 times less likely to develop depression compared to those who had less than $600. However, women who used implants (Jadelle) and pills were more likely to develop depression with a p-value of 2.4x10-2 and 1.40x10-2, respectively, than those who used Norplant, respectively. In addition, women who use HCs for one year and more/over are less likely to develop depression compared to those who use HCs for more than 3 months and 6 months, respectively. In conclusion, housewives, low-income level, type of HC, and long duration of HCs were the determinants of depression. As a result, women should be aware of the Hormonal Contraceptives' side effects related to depression and seek the advice of doctors or other medical professionals.
Abdulahi, M., Kakaire, O., & Namusoke, F. (2020). Determinants of modern contraceptive use among married Somali women living in Kampala; a cross-sectional survey. Reproductive Health, 17(1), 1-9. https://doi.org/10.1186/s12978-020-00922-x
Albawardi, I., Alqahtani, A. H., Aljamea, D. A., Aljaafari, S. A., Aldulijan, F. A., Almuhaidib, S. R., Elamin, M., & Al Qahtani, N. H. (2022). Hormonal Contraception Use and Depression Among Women in Saudi Arabia. Journal of Multidisciplinary Healthcare, 15, 1677-1688. https://doi.org/10.2147/JMDH.S371203
Alfaifi, M., Najmi, A. H., Swadi, K. H., Almushtawi, A. A., & Jaddoh, S. A. (2021). Prevalence of contraceptive use and its association with depression among women in the Jazan province of Saudi Arabia. Journal of Family Medicine and Primary Care, 10(7), 2503-2511. https://doi.org/10.4103/jfmpc.jfmpc_1308_20.
Asaolu, I., Nuño, V. L., Ernst, K., Taren, D., & Ehiri, J. (2019). Healthcare system indicators associated with modern contraceptive use in Ghana, Kenya, and Nigeria: Evidence from the Performance Monitoring and Accountability 2020 data. Reproductive Health, 16, 152. https://doi.org/10.1186/s12978-019-0816-4
Böttcher, B., Radenbach, K., Wildt, L., & Hinney, B. (2012). Hormonal contraception and depression: A survey of the present state of knowledge. Archives of Gynecology and Obstetrics, 286(1), 231–236. https://doi.org/10.1007/s00404-012-2268-6
Cameron, I. M., Crawford, J. R., Lawton, K., & Reid, I. C. (2008). Psychometric comparison of PHQ-9 and HADS for measuring depression severity in primary care. British Journal of General Practice, 58(546), 32-36. https://doi.org/10.3399/bjgp08X263794
Cooper, D. B., Patel, P., & Mahdy, H. (2022). Oral contraceptive pills. In StatPearls [Internet]. StatPearls Publishing. Retrieved November 24, 2022, from https://www.ncbi.nlm.nih.gov/books/NBK430882/
Ditzell, J., & Sharkey, L. (2021). Can one reduce the effectiveness of the other? 11 Things to Know About Using Birth Control and Antidepressants. Healthline. Retrieved from https://www.healthline.com/health/birth-control/birth-control-and-antidepressants
Ehsanpour, S., Aghaii, A., & Kheirabadi, G. (2012). The association of contraceptive methods and depression. Iranian Journal of Nursing and Midwifery Research, 17(3), 234–238. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3696218/
Family Doctor. (2023). Hormonal contraception and depression - What does the evidence tell us? Women's Health. Editorial Team Auckland New Zealand. Retrieved from https://www.familydoctor.co.nz/categories/womens-health/hormonal-contraception-and-depression-what-does-the-evidence-tell-us/
Fruzzetti, F., & Fidecicchi, T. (2020). Hormonal contraception and depression: Updated evidence and implications in clinical practice. Clinical Drug Investigation, 40(12), 1097–1106. https://doi.org/10.1007/s40261-020-00966-8
Gure, F., Dahir, M. K., Yusuf, M., & Foster, A. M. (2016). Emergency contraception in post-conflict Somalia: An assessment of awareness and perceptions of need. Studies in Family Planning, 47(1), 69–81. https://doi.org/10.1111/j.1728-4465.2016.00047.x
Kame, L. (2022). Contraceptive use among women in Kenya 2010-2021. Statista. Retrieved from https://www.statista.com/statistics/1281068/contraceptive-prevalence-rate-among-women-in-kenya/
Martell, S., Marini, C., Kondas, C. A., & Deutch, A. B. (2023). Psychological side effects of hormonal contraception: A disconnect between patients and providers. Contraception and Reproductive Medicine, 8, 9. https://doi.org/10.1186/s40834-022-00204-w
Mohamed, A. F., & Sundberg, L. R. (2022). "Using contraceptives is abandoning our culture": A qualitative study of contraceptive use among Somali women in Finland. Sexual and Reproductive Healthcare, 32, 100718.
Mohammed, A., Woldeyohannes, D., Feleke, A., & Megabiaw, B. (2014). Determinants of modern contraceptive utilisation among married women of reproductive age group in North Shoa Zone, Amhara Region, Ethiopia. Reproductive Health, 11, 13. https://doi.org/10.1186/1742-4755-11-13
Mu, E., & Kulkarni, J. (2022). Hormonal contraception and mood disorders. Australian Prescriber, 45(3), 75-79. https://doi.org/10.18773/austprescr.2022.025
New Zealand Family Planning. (2013). Benefits of contraception use. https://www.familyplanning.org.nz/news/2013/benefits-of-contraception-use
Odusolu, P. O., & Eyong, E. M. (2020). Uptake and discontinuation of Jadelle implant use in University of Calabar Teaching Hospital, Calabar, Nigeria. Nigerian Journal of Medicine, 29(2), 286-290. https://doi.org/10.4103/NJM.NJM_61_20
Pinto-Meza, A., Serrano-Blanco, A., Peñarrubia, M. T., Blanco, E., & Haro, J. M. (2005). Assessing depression in primary care with the PHQ-9: Can it be carried out over the telephone? Journal of General Internal Medicine, 20(8), 738-742. https://doi.org/10.1111/j.1525-1497.2005.0144.x
Prata, N. (2007). The need for family planning. Population and Environment, 28, 212-222. https://doi.org/10.1007/s11111-007-0042-9
Ramdhan, R. C., Simonds, E., Wilson, C., Loukas, M., Oskouian, R. J., & Tubbs, R. S. (2018). Complications of subcutaneous contraception: A review. Cureus, 10(1), e2132. https://doi.org/10.7759/cureus.2132
Schaffir, J., Worly, B. L., & Gur, T. L. (2016). Combined hormonal contraception and its effects on mood: A critical review. European Journal of Contraception and Reproductive Health Care, 21(5), 347-355. https://doi.org/10.1080/13625187.2016.1217327
Somali Health and Demographic Survey. (2020). The Federal Republic of Somalia. https://somalia.unfpa.org/sites/default/files/pubpdf/FINAL%20SHDS%20Report%202020_V7_0.pdf
Singata-Madliki, M., Carayon-Lefebvre d’Hellencourt, F., Lawrie, T.A., Balakrishna, Y., & Hofmeyr, G.J. (2021). Effects of three contraceptive methods on depression and sexual function: An ancillary study of the ECHO randomised trial. International Journal of Gynecology and Obstetrics, 154, 256-262. https://doi.org/10.1002/ijgo.13594.
Sivin, I. (2003). Risks and benefits, advantages and disadvantages of levonorgestrel-releasing contraceptive implants. Drug Safety, 26(5), 303-335. doi: 10.2165/00002018-200326050-00002
Skovlund, C.W., Morch, L.S., Kessing, L.V., & Lidegaard, O. (2016). Association of hormonal contraception with depression. JAMA Psychiatry, 73(11), 1154-1162. doi: 10.1001/jamapsychiatry.2016.2387.
Tamburrino, M.B., Lynch, D.J., Nagel, R.W., & Smith, M.K. (2009). Primary care evaluation of mental disorders (PRIME-MD) screening for minor depressive disorder in primary care. Primary Care Companion to The Journal of Clinical Psychiatry, 11(6), 339-343. doi: 10.4088/PCC.08.m00711.
Copyright (c) 2023 Abdi M. Salad, Hodan A. Duale, Abdi Gele, Abdiqani Ahmed Farah
This work is licensed under a Creative Commons Attribution 4.0 International License.